ENDORAA: Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Recruiting
CT.gov ID
NCT03555903
Collaborator
(none)
500
1
117.1
4.3

Study Details

Study Description

Brief Summary

Endometriosis is a common gynaecologic disease affecting 5 to 15% women of reproductive age and up to 40% of infertile women. It is characterized by the presence of active endometrial tissue outside the uterine cavity, potentially causing invalidating chronic pelvic pain and infertility. It is therefore crucial to limit the progression and/or recurrence of the disease, and to improve the quality of life of affected women.

Deep infiltrating endometriosis (DIE), an advanced form of the disease, is defined by the invasion of an anatomical structure and organ close to the uterus (i.e. uterosacral ligament, rectovaginal space, recto-sigmoidal colon or bladder), or by a peritoneal invasion greater than 5mm. The management of DIE is unfortunately not yet based on high-level evidence data; it mainly depends on the localization of the disease, the extend of the invasion and the severity of the symptoms. In the absence of clear guidelines based on empirical data, the choice between surgical or medical treatment remains difficult and controversial.

To improve optimal DIE management, the investigators aim to create a prospective database reporting on DIE surgically treated in a teaching hospital in Lyon/France (Centre hospitalier universitaire Lyon Sud)

Data on known risks factors, symptoms (pain), quality of life, infertility history and disease management will be obtained using self-questionnaires, clinic, paraclinic, surgical and histological records as follow.

  1. Each patient will be asked to fill in electronics protected on-line forms: the first one before surgery, followed by three follow-up forms at 1, 2 and 5 years after surgery.

  2. The surgeon will be asked to fill in two electronic protected on-line forms: the first one at the time of surgery and the second one during a post-operative consultation (one month after surgery).

The questionnaires used in this study are similar to those used for the Endometriosis database "CIRENDO" (explain briefly what it is), which will ultimately allow us to pool the data from the 2 databases.

This French prospective study will advance the scientific knowledge on DIE surgical treatment and, by helping evaluate the impact of the surgery on the quality of life and fertility of affected women, will guide future recommendations for an optimal management of this invalidating disease.

Condition or Disease Intervention/Treatment Phase
  • Other: Endometriosis cohort

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Endometriosis cohort

The aim of the study is to advance the scientific knowledge of deep infiltrating endometriosis (DIE) and to evaluate the impact of surgery on the quality of life and the fertility of affected women.

Other: Endometriosis cohort
The investigator record data on risks factors, symptoms (pain), quality of life (using standardized quality of life questionnaires), infertility history, and management of the disease with a 5-years follow up. Different surgical procedures exist to treat DIE and are they are described in the database, to allow comparison.

Outcome Measures

Primary Outcome Measures

  1. The impact of the management of deep endometriosis on the quality of life [5 years]

    Evolution of SF 36 quality of life scores.

  2. The impact of the management of deep endometriosis on the quality of life [5 years]

    Evolution of EHP-30 quality of life scores.

Secondary Outcome Measures

  1. Describe endometriosis [5 years]

    Description of the study population : Socio-demographic data

  2. Describe risk factors of the disease. [5 years]

    Postoperative complications (DINDO classification)

  3. Describe diagnostic delay of the disease. [5 years]

    Description of diagnostic.

  4. Describe diagnostic management of the disease. [5 years]

    Description of therapeutic management : Diagnostic loadings

  5. Impact of the management of deep endometriosis on the use of assisted reproductive therapy. [5 years]

    Impact on fertility.

  6. Describe risk factors of the disease. [5 years]

    Recurrence of endometriosis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • surgically management for deep endometriosis
Exclusion Criteria:
  • No surgical management necessary

  • Isolated Adenomyosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre hospitalier Lyon sud Pierre-Bénite France 69495

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT03555903
Other Study ID Numbers:
  • 69HCL17_0813
First Posted:
Jun 14, 2018
Last Update Posted:
Jul 27, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2021